CHRNA7 and atherosclerosis: Although IL-6 has been implicated in the pathogenesis of atherosclerosis [135], in vitro studies have demonstrated that the activation of α7-nAChRs attenuates the release of IL-6 by macrophages [136], and the level of IL-6 is increased in patients with CAS [119].